Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Fortress Biotech, Inc.

Get SEC filing alerts via email and in your feed for Fortress Biotech, Inc.

FBIO FBIOP

Fortress Biotech, Inc.

About Fortress Biotech, Inc.

Fortress Biotech, Inc. is a biopharmaceutical company that acquires, develops, and commercializes innovative drug candidates across various therapeutic areas. It operates through subsidiaries and partner companies, focusing on product revenue, royalties, and equity holdings. The company collaborates with leading research institutions and industry partners to bring targeted therapies to market, emphasizing immuno-oncology, dermatology, and rare diseases.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Fortress Biotech, Inc.

1
1
Fortress Biotech, Inc. Fortress Biotech Reports 22% Revenue Growth and $137.2 Million Net Income in Latest Quarter

Via official filing (AI summary) | 21 days ago | 0 comments

2
1
Fortress Biotech, Inc. Fortress Biotech Reports 21% Revenue Growth and Net Income Turnaround in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

3
1
Fortress Biotech, Inc. Fortress Biotech Reports 10% Revenue Growth to $16.4 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

4
1
Fortress Biotech, Inc. Fortress Biotech Reports $13.1 Million Revenue and $24.7 Million Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

5
1
Fortress Biotech, Inc. Fortress Biotech Reports 58% Decline in Net Revenue, Net Loss Increases in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments